CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection

Journal of Clinical Virology

Volumn 61, Issue 1, 2014, Pages 40-46

  Cao, Wei ^a   Qiu, Zhifeng ^a   Zhu, Ting ^a   Li, Yanling ^a   Han, Yang ^a   Li, Taisheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

HBV core protein; Inactive HBsAg carrier; Specific T cell response

Indexed keywords

CD27 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CORE PROTEIN; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 2; VIRUS DNA; CCR7 PROTEIN, HUMAN; HEPATITIS B CORE ANTIGEN; P22 CORE PROTEIN, HEPATITIS B VIRUS;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEALTH STATUS; HEPATITIS B; HUMAN; HUMAN CELL; MALE; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; IMMUNOLOGY; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD27; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HEPATITIS B CORE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; RECEPTORS, CCR7; T-LYMPHOCYTE SUBSETS; VIRAL CORE PROTEINS;

EID: 84905125162     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.06.022     Document Type: Article

References (32)

1. Bertoletti A., Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 2006, 87:1439-1449.
2. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., et al. The role of virus-specific CD8 cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000, 191:1269-1280.
3. Chisari F.V., Ferrari Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995, 13:29-60.
4. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., Sette A. Human histocompatibility leucocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 1997, 100:503-513.
5. Webster G.J., Reignat S., Brown D., Ogg G.S., Jones L., Seneviratne S.L., et al. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004, 78:5707-5719.
6. Mizukoshi E., Sidney J., Livingston B., Ghany M., Hoofnagle J.H., Sette A., et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol 2004, 173(9):5863-5871.
7. Shi T.D., Wu Y.Z., Jia Z.C., Zhou W., Zou L.Y. Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs. World J Gastroenterol 2004, 10(13):1902-1906.
8. Krausa P., Browning M.J. HLA-A2 polymorphism and immune functions. Eur J Immunogenet 1996, 23:261-274.
9. Tan A.T., Loggi E., Boni C., Chia A., Gehring A.J., Sastry K.S., et al. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 2008, 82(22):10986-10997.
10. Isogawa M., Furuichi Y., Chisari F.V. Oscillating CD8+ T cell effector functions after antigen recognition in the liver. Immunity 2005, 23(1):53-63.
11. Chang J.J., Thompson A.J., Visvanathan K., Kent S.J., Cameron P.U., Wightman F., et al. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 2007, 46(5):1332-1340.
12. Boni C., Fisicaro P., Valdatta C., Amadei B., Di Vincenzo P., Giuberti T., et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007, 81(8):4215-4225.
13. Romero P., Zippelius A., Kurth I., Pittet M.J., Touvrey C., Iancu E.M., et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007, 178(7):4112-4119.
14. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002, 8(4):379-385.
15. Kim C.H., Rott L., Kunkel E.J., Genovese M.C., Andrew D.P., Wu L., et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001, 108(9):1331-1339.
16. Masopust D., Vezys V., Marzo A.L., Lefrancoiset L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001, 291:2413-2417.
17. Hintzen R.Q., De Jong R., Lens S.M., van Lier P.A. CD27: marker and mediator of T cell activation. Immunol Today 1994, 15(7):307-311.
18. Lok A.-S.F., McMahon B.J. AASLD practice guidelines chronic hepatitis B: update 2009. Hepatology 2009, 50(3):1-36.
19. Bertoletti A., Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2012, 61:1754-1764.
20. Sandra P., Shilpa C., Antonio R., Alexander E., Roger W., Nikolai V.N. CD8+ T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic Functions. J Immunol 2010, 184:287-295.
21. Fisicaro P., Valdatta C., Massari M., Loggi E., Biasini E., Sacchelli L., et al. Antiviral intrahepatic T- cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010, 138:682-693.
22. Chu C., Liaw Y.F. Natural history of chronic hepatitis B virus infection: an immunopathological study. J Gastroenterol Hepatol 1997, 12:S218-S222.
23. Sharma S.K., Saini N., Chwla Y. Hepatitis B virus: inactive carriers. Virol J 2005, 82-86.
24. Hsu Y.S., Chien R.N., Yeh C.T., Sheen I.S., Chiou H.Y., Chu C.M., et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002, 35:1522-1527.
25. De Franchis R., Meucci G., Vecchi M., Tatarella M., Colombo M., Del Ninno E., et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993, 118:191-194.
26. Gigi E., Lalla T., Orphanou E., Sinakos E., Vrettou E., Gigi M.R. Long term follow-up of a large cohort of inactive HBsAg (+)/HBeAg (-)/anti-HBe (+) carriers in Greece. J Gastrointestin Liver Dis 2007, 16(1):19-22.
27. Perillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001, 120:1009-1022.
28. Zhang G.L., Yang Y., Feng Z., Zhang Y.Z., Feng M.L., Ji Y.H., et al. Report of HLA distribution of Chinese bone marrow bank (Shanghai). Chin J Organ Transplan 2001, 22(3):179-185.
29. Wu G.G., Deng Z.H., Gao S.Q., Cheng L.H., Jin S.Z., Zhou D., et al. Study of HLA polymorphism in the 6965 han bone marrow registry donors. Chin J Hematol 2004, 25(8):473-477.
30. Tan A.T., Koh S., Goh V., Bertoletti A. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective. J Gastroenterol Hepatol 2008, 23(6):833-843.
31. + T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 2004, 34(4):999-1010.
32. Boni C., Laccabue D., Lampertico P., Giuberti T., Viganò M., Schivazappa S., et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology 2012, 143(4):963-973.